107
Views
2
CrossRef citations to date
0
Altmetric
Diagnostic Tests

Mannitol Challenge Does Not Confirm Bronchial Hyperreactivity in Some Histamine-Responsive Asthmatic Children

, M.D., Ph.D., , M.D., Ph.D. & , M.D., Ph.D.
Pages 817-821 | Published online: 14 Sep 2012

References

  • Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143–178.
  • Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S, Bagnasco M, Canonica GW. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995; 96:971–979.
  • Salome CM, Peat JK, Britton WJ, Woolcock AJ. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma. Clin Allergy 1987; 17:271–281.
  • McGrath KW, Fahy JV. Negative methacholine challenge tests in subjects who report physician-diagnosed asthma. Clin Exp Allergy 2010; 41:46–51.
  • Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ. Guidelines for methacholine and exercise challenge testing – 1999. Am J Respir Crit Care Med 2000; 161:309–329.
  • Barben J, Riedler J. Measurement of bronchial responsiveness in children. In: Hammer J, Eber E, eds. Paediatric Pulmonary Function Testing. Basel: Karger, 2005:125–136.
  • Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, Gonda L, Walsh A, Clark AR. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997; 156:758–765.
  • Porsbjerg C, Backer V, Joos G, Kerstjens HA, Rodriguez-Roisin R. Current and future use of the mannitol bronchial challenge in everyday clinical practice. Clin Respir J 2009; 3:189–197.
  • Leuppi JD, Brannan JD, Anderson SD. Bronchial provocation tests: the rationale for using inhaled mannitol as a test for airway hyperresponsiveness. Swiss Med Wkly 2002; 132:151–158.
  • Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003; 22:491–496.
  • Clearie KL, Williamson PA, Vaidyanathan S, Short P, Goudie A, Burns P, Hopkinson P, Meldrum K, Howaniec L, Lipworth BJ. Disconnect between standardized field-based testing and mannitol challenge in Scottish elite swimmers. Clin Exp Allergy 2010; 40:731–737.
  • Gade E, Thomsen SF, Porsbjerg C, Backer V. The bronchial response to mannitol is attenuated by a previous methacholine test: but not vice versa. Clin Exp Allergy 2009; 39:966–971.
  • Horsman TA, Duke RK, Davenport PW. Airway response to mannitol challenge in asthmatic children using impulse oscillometry. J Asthma 2009; 46:600–603.
  • Porsbjerg C, Lund TK, Pedersen L, Backer V. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO. J Asthma 2009; 46:606–612.
  • Singapuri A, McKenna S, Brightling CE, Bradding P. Mannitol and AMP do not induce bronchoconstriction in eosinophilic bronchitis: further evidence for dissociation between airway inflammation and bronchial hyperresponsiveness. Respirology 2010; 15: 510–515.
  • Moloney ED, Griffin S, Burke CM, Poulter LW, O’Sullivan S. Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus. Respir Med 2003; 97:928–932.
  • Thompson CA. FDA approves mannitol bronchial-challenge test kit. Am J Health Syst Pharm 2010; 67: 1886.
  • Rosenthal R. Methodologies of aerosol delivery. In: Spector SL, ed. Provocation Testing in Clinical Practice. New York: Marcel Dekker, 1995:215–229.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
  • Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948–968.
  • Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: A phase 3 comparison study with hypertonic (4.5%) saline. Respir Res 2005; 6:144.
  • Anderson SD. Exercise-induced bronchoconstriction in the 21st century. J Am Osteopath Assoc 2011; 111(11 Suppl. 7):S3–S10.
  • Anderson SD, Kippelen P. Assessment and prevention of exercise-induced bronchoconstriction. Br J Sports Med 2012; 46:391–396.
  • Spector S, Anderson SD, Charlton B, Weiler JM, Nichols S. Members of the A-305 study team. Mannitol inhalational challenge. Will it replace methacholine or histamine? Proc Am Thorac Soc 2009; 6:331.
  • Anderson SD, Pearlman DS, Rundell KW, Perry CP, Boushey H, Sorkness CA, Nichols S, Weiler JM. Reproducibility of the airway response to an exercise protocol standardized for intensity, duration, and inspired air conditions, in subjects with symptoms suggestive of asthma. Respir Res 2010; 11:120.
  • Tetzlaff K, Leplow B, ten Thoren C, Dahme B. Perception of dyspnea during histamine- and methacholine-induced bronchoconstriction. Respiration 1999; 66:427–433.
  • Subbarao P, Brannan JD, Ho B, Anderson SD, Chan HK, Coates AL. Inhaled mannitol identifies methacholine-responsive children with active asthma. Pediatr Pulmonol 2000; 29:291–298.
  • Wood LG, Powell H, Gibson PG. Mannitol challenge for assessment of airway responsiveness, airway inflammation and inflammatory phenotype in asthma. Clin Exp Allergy 2010; 40:232–241.
  • Leuppi JD, Salome CM, Jenkins CR, Koskela H, Brannan JD, Anderson SD, Andersson M, Chan HK, Woolcock AJ. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J 2001; 18:444–450.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.